Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) receptor agonists are efficacious glucose-lowering medications with salient benefits for body weight and cardiovascular events. This class of medications is now recommended as the top priority for patients with established cardiovascular disease or indicators of high...

Descripción completa

Detalles Bibliográficos
Autores principales: Choe, Hun Jee, Cho, Young Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937847/
https://www.ncbi.nlm.nih.gov/pubmed/33677922
http://dx.doi.org/10.3803/EnM.2021.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937847/
https://www.ncbi.nlm.nih.gov/pubmed/33677922
http://dx.doi.org/10.3803/EnM.2021.102

Ejemplares similares